The news is by your side.

In a 24-hour Period, Five Dengue Patients Died in Bangladesh

According to a top DGHS official, dengue fever will begin to decline in the third week of this month. Five more dengue victims died in the last 24 hours, bringing the total number of dengue deaths in Bangladesh this year to 192.

According to the Directorate General of Health Services, dengue cases in Bangladesh have continued to rise, with 888 additional individuals hospitalized by the mosquito-borne fatal illness during the same period (DGHS).

475 of the new patients were admitted to various hospitals in Dhaka, while 413 were admitted to facilities outside the capital city.

A total of 3,248 dengue patients are presently being treated in hospitals across the country, including 1,915 in the capital.

The Business Standard (TBS) quoted Professor Dr. Nazmul Islam, director of the DGHS Communicable Disease Control unit, as saying, “Dengue fever is projected to begin to decline in the second or third week of this month. Dengue fever will return if it rains again.”

“If city corporations continue to eradicate mosquitoes, waste management is good, and people keep their surroundings clean, the number of patients will begin to decrease,” he added.

The DGHS reported the first dengue-related mortality of the season on June 21. So far this year, the directorate has documented 46,486 dengue cases and 43,046 recoveries.

This year’s dengue cases and fatalities were the highest since 2000 when the government began formally tracking dengue. In 2000, there were 5,551 dengue cases and 93 deaths.

However, the largest number of dengue cases and deaths to date was reported in 2019, with 101,354 cases and 179 deaths.

After years of research, Japan’s pharmaceutical behemoth Takeda Pharmaceutical Company has created “Qdenga,” a dengue vaccine that offers hope for future generations.

The vaccine has already been licensed in Indonesia, and it is scheduled to hit the market in early 2023. Furthermore, a number of other countries, including the United States, have expressed interest in approving the drug.

However, Bangladesh has shown little or no interest in the vaccine so far, citing a desire to focus on preventive measures in the fight against mosquito-borne disease.

Furthermore, authorities say they are monitoring vaccine updates in other countries as well as how the World Health Organization (WHO) responds to them.

This year has seen the worst dengue outbreak in Bangladesh. As of Wednesday, 187 people had died as a result of dengue infection, the most in the last 22 years.

Comments are closed, but trackbacks and pingbacks are open.